Tritonix.ai

News / Taiwan / cnyes

Apex Medical Expects Strong H2 Growth, Targeting 20% Annual Rise in Overseas Markets

Health Technology · Medical Specialties · cnyes · 2026-08-26

6918

Orthopedic medical device manufacturer Apex Medical (6918) projects a stronger second half of the year, driven by international expansion and new product launches.

What Happened

Operational Outlook: Apex Medical (6918-TW) CEO Luo Xiang-wei stated that with the expansion of domestic product lines and the maturation of overseas strategies, the company expects second-half performance to surpass the first half, with H2 revenue accounting for over 50% of the annual total.

International Expansion: The company is actively penetrating Southeast Asian markets such as Singapore, Malaysia, Thailand, and Vietnam, while also exploring entry into Japan and Indonesia, aiming for a 20% annual growth rate in overseas revenue over the next few years.

China Market Strategy: In response to China's centralized procurement policies, Apex has shifted its product mix, with non-centralized procurement items now accounting for 70% of its Chinese revenue, led by strong sales of bunion correction and carbon fiber bone plate products.

Strategic Partnerships: Apex is currently in discussions with Japanese distributors regarding potential OEM collaborations, with further meetings scheduled for September, which could serve as a significant catalyst for the company's international growth.

Read original

More in Health Technology

Foreign Investors' Top KOSDAQ Picks: Alteogen and PharmaResearch Lead Buying

Health Technology · yonhap_finance · 2026-08-26

On November 26, foreign investors in the KOSDAQ market heavily accumulated shares of Alteogen and PharmaResearch while offloading Daehan Optic and Jusung Engineering.

Institutional Investors' Top KOSDAQ Picks: PharmaResearch and HPSP Lead Buying

Health Technology · yonhap_finance · 2026-08-26

On November 26, institutional investors in the KOSDAQ market favored PharmaResearch and HPSP, while offloading shares of Jusung Engineering and HLB.

PharmaEssentia Hits Record High on Japan Drug Approval and US Outlook

Health Technology · cnyes · 2026-08-26

PharmaEssentia's shares reached a record high after receiving Japanese approval for its ET drug, with US regulatory approval expected by late August.

6446

Latest in Taiwan

Taiwan's High-Priced Stocks Surge: Largan and Alchip Lead 8 Limit-Up Gains as 'Ten-Thousand Dollar' Stock Battle Intensifies

Electronic Technology · cnyes · 2026-08-26

Taiwan stocks rallied strongly today, with high-priced stocks leading the charge as eight companies hit the daily limit-up, while the battle for the top spot among 'ten-thousand dollar' stocks heats up.

1590, 2059, 3008, 3443, 3653, 5274, 6446, 6669, 6805, 6949

LuxNet Reports Strong July Earnings with EPS of NT$0.92

Electronic Technology · economic_daily · 2026-08-26

LuxNet announced its July financial results, posting a net profit of NT$131 million, a 65.82% year-over-year increase, driven by strong demand for optical modules.

4979

Nvidia Earnings Eyed as Taiwan Stocks Rally; Analysts Warn of Volume Hurdles

Electronic Technology · economic_daily · 2026-08-26

Taiwan stocks surged on Nvidia earnings optimism, but analysts advise caution, suggesting a 50% cash position until volume confirms a breakout above 46,000.

1303, 2308, 2330, 2383, 2454, 3008, 3017, 3037, 3653, 6949

Taiwan Stocks Reclaim 45K Level as Institutional Investors Pour in 59.4 Billion TWD

Electronic Technology · economic_daily · 2026-08-26

Taiwan stocks surged 663 points on heavy institutional buying, with broad-based gains across tech, plastics, and biotech sectors driving the index higher.

1303, 1312, 2308, 2330, 2383, 2426, 2454, 3008, 3017, 3037, 3406, 3543, 3653, 4188, 6223, 6226, 6278, 6405, 6446, 6547, 6617, 6668, 6885, 6949